Havens Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Havens Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-103,760	Closed	-$2.17M	–	49
2016 Q3	$2.17M	Buy	+103,760	New	+$1.19M	1.69%	17

Havens Advisors's VTAE Position: Q4 2016 in Review

Havens Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 103,760 shares — an estimated $2.17M sold.

Havens Advisors first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $2.17M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Havens Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Havens Advisors sold 103,760 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $2.17M.
Havens Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Havens Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.17M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Havens Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.